Lockheed upgraded, Oracle downgraded: Wall Street's top analyst calls
Lockheed upgraded, Oracle downgraded: Wall Street's top analyst calls
Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire
Shares of Boston Scientific rose sharply Wednesday after the firm posted better-than-expected quarterly results.
Weak oil prices, limited shale acreage to hit energy M&A in 2025, Enverus says
HOUSTON (Reuters) -The U.S. upstream oil and gas M&A market is bracing for the most challenging conditions since the COVID-19 pandemic as oil prices slump and prime acreage dries up, analytics firm Enverus said on Wednesday, even though dealmaking jumped last quarter to the second-best start to the year since 2018. The expected downturn in mergers and acquisitions follows a series of blockbuster takeovers by oil and gas majors in recent years, which culminated in a record $192 billion worth of deals done in 2023. There were $17 billion worth of deals disclosed in the quarter ended March 31, but activity was disproportionately driven by Diamondback Energy, which accounted for almost half of total value, said Enverus Intelligence Research principal analyst, Andrew Dittmar.
Riot Platforms Secures $100M Bitcoin-Backed Credit Line From Coinbase
The funds will be used for strategic initiatives and general corporate purposes, and cash drawn from the line will carry at least a 7.75% interest rate.
Markets jump after Trump softens rhetoric on China and Fed chair
U.S. stocks opened higher Wednesday after President Donald Trump signaled a softer stance toward the eye-watering tariffs he had set for China, while also stating he would not make an immediate change in leadership at the Federal Reserve.
4 Stocks to Watch as Bitcoin Gears Up to Surpass $100,000 Again
Stocks like NVDA, V, ACN and HIVE are poised to gain when Bitcoin resumes its rally.
3 Small-Cap Stocks in the Doghouse
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
1 of Wall Street’s Favorite Stock Worth Investigating and 2 to Brush Off
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
1 of Wall Street’s Favorite Stock with Solid Fundamentals and 2 to Be Wary Of
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 to Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.